Inactive Instrument

Biondvax Pharmaceuticals Ltd Stock Other OTC

Equities

Duration

Period

Style

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	19-07-16	PU
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	19-07-08	PU
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	19-06-26	PU
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	19-06-18	PU
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	19-06-10	PU

Sector

	1st Jan change	Capi.
MODERNA, INC.	+16.71%	44.48B
LONZA GROUP AG	+42.66%	40.57B
IQVIA HOLDINGS INC.	-7.92%	38.82B
ALNYLAM PHARMACEUTICALS, INC.	+33.09%	32.22B
CELLTRION, INC.	-7.10%	27.84B
ICON PUBLIC LIMITED COMPANY	+14.46%	26.79B
UNITED THERAPEUTICS CORPORATION	+46.73%	14.31B
MEDPACE HOLDINGS, INC.	+34.07%	12.7B
BIO-TECHNE CORPORATION	-7.61%	11.23B